Search is Powered by Google
Primary Care / General Practice News

WSJ Examines Financial Incentives For Physicians To Switch Patients To Less-Expensive, Generic Medications

Main Category: Primary Care / General Practice
Also Included In: Public Health;  Pharma Industry / Biotech Industry
Article Date: 25 Jan 2008 - 9:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

The Wall Street Journal on Thursday examined how some health insurers are "drawing scrutiny for offering financial incentives" as part of efforts to encourage physicians to switch patients from brand-name medications to less-expensive, generic treatments.

According to the Journal, although large pharmaceutical companies "have long gone to great lengths" and have invested "billions of dollars plying physicians with samples, educational lunches and speaker fees" to promote their products, health insurers are "trying to trump those perks" with monetary gifts and higher reimbursements. Health insurers maintain that increased use of generic medications will reduce costs for patients, employers and health care providers, and many physicians "argue that it's only right to reimburse them" for the time required to determine whether less-expensive, generic medications are "better or as good" for patients than brand-name treatments, the Journal reports.

However, lawmakers and patient advocacy groups have raised concerns that "injecting financial incentives into what ... should be a purely medical decision" could affect quality of care, and medical societies maintain that the practice places physicians in the "ethically questionable position of taking a payment that patients know nothing about," according to the Journal. In response to concerns about the practice, the American Medical Association recently published an online advisory titled "Kickback Questions and Answers." According to the advisory, "Accepting payment for moving a patient from a brand name to a generic could be viewed as an anti-kickback statute violation" (Fuhrmans, Wall Street Journal, 1/24).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation© 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

add medical news today to your facebook

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


These are the most read articles from this news category for the last 6 months:
Top Article Star
Earwax Removal: National Guidelines Released
29 Aug 2008
The American Academy of Otolaryngology - Head and Neck Surgery Foundation (AAO-HNSF) will issue the first comprehensive clinical guidelines to help health care practitioners identify patients with cerumen (commonly referred to as earwax) impaction...


When Your Cycle Becomes a Major Headache
When Your Cycle Becomes a Major Headache

Cathy's gets as many as 12 to 15 headaches a month and they are all associated with her menstrual cycle. Migraines like hers tend to last longer and be more severe than other migraines. Figuring out what was triggering her headaches helped Cathy and her doctor come up with a successful treatment plan.

more videos are available in our health videos section.